<DOC>
	<DOCNO>NCT02306993</DOCNO>
	<brief_summary>This research study two purpose . The first purpose determine whether sickle cell trait ( SCT ) risk factor development bone thin early age expect . Nearly 10 % African Americans ( AA ) carry sickle cell trait unaware . African Americans less likely develop thin bone white , sustain bone fracture , likely die . We believe sickle cell trait may lead bone thin predispose subset African Americans dangerously thin bone . The second purpose try understand individual sickle cell disease ( SCD ) thinner bone healthy individual . Doctors already discover people sickle cell disease thin bone , determine . Our study try identify whether bone thin body make enough bone body lose bone make .</brief_summary>
	<brief_title>Sickle Cell Hemoglobinopathies Bone Health</brief_title>
	<detailed_description>SCD hereditary disease arise two parent carry sickle cell trait ( SCT ) conceive child . SCT clinically silent common African Americans ~10 % prevalence , although carrier unaware status . There data bone mineral density ( BMD ) vitamin D status individual . Although clear SCD accelerate bone thin effect SCT bone metabolism fracture study . Although incidence hip fracture AA woman half white woman , etiology risk factor fracture AA woman clearly define , intrigue postulate SCT may relationship bone metabolism fracture risk population , thus contribute racial disparity . We hypothesize mechanism underlie alter bone homeostasis SCD different general population perhaps similar SCT . We also hypothesize SCT state reduce bone mineralization may contribute racially disparate outcome among AAs bone fracture . Our objective ( 1 ) define mechanism bone loss SCD ( 2 ) evaluate parameter bone metabolism human subject SCT compare normal hemoglobin SCD . We investigate effect SCD SCT bone homeostasis premenopausal AA subject via serum bone turnover marker , calciotrophic hormone bone mineral density ( BMD ) test . We hypothesize premenopausal AA woman SCT significantly low BMD high serum bone turnover marker race- age-matched control AA woman . In addition , explore Vitamin D status relationship bone turnover BMD three group . We postulate bone homeostasis SCT subject intermediate healthy control subject SCD .</detailed_description>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Hemoglobinopathies</mesh_term>
	<mesh_term>Sickle Cell Trait</mesh_term>
	<criteria>Age 1845 year . Female . Regular menstrual period . Selfidentification African American race . Taking oral contraceptive medication know influence bone metabolism ( e.g . Glucocorticoids , antiresorptive anabolic medication osteoporosis , pharmacologic Vit D dose ) . Known metabolic bone disorder ( e.g . uncontrolled thyroid disease , hyperparathyroidism ) . Pregnant , breastfeeding , within 3 month postpartum . Taking investigational drug .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Sickle Cell Disease ( SCD )</keyword>
	<keyword>Sickle Cell Trait ( SCT )</keyword>
</DOC>